Value Range

The Value Range

At $12.25, the DQ ADS trades below the cash the parent looks through to and at roughly a fifth of book. The downside is bounded by a hard, impairment-proof pool of about $2.0 billion in cash and deposits; the upside — a re-rating toward book or the Shanghai listing's mark — and the soft $3.4 billion plant value both depend on Beijing enforcing an above-cost polysilicon price by mid-2026. This chapter reconciles the report's pillars into that range and names what to watch.

What the price implies

The arithmetic is stark. Daqo has 338,330,684 ordinary shares outstanding — 67.7 million ADS at five shares each [1]. At $12.25 that is an $0.83 billion equity value against $4.41 billion of equity attributable to the ADS and $5.92 billion of total equity including the minority [2]. Book value is about $65 per ADS; the market pays 0.19 times it.

Source: ADS price as reported, July 2, 2026; shares, equity and book value from the FY2025 Annual Report, Consolidated Balance Sheets [3]; price-to-book derived.

Four reference points frame the range. The price sits below the cash the ADS looks through to, well below both book and the value the Shanghai STAR market puts on the same operating company, and near the very bottom of what a liquidation-style read would support. Each anchor was built earlier in this report; the point here is that they bracket a wide gap.

Sources: price as reported; look-through cash per Where the Cash Sits; look-through STAR mark per The Listing Gap; book value from the FY2025 Annual Report [4].

Two floors, hard and soft

The floor under the ADS is not one number but two, and they behave differently in a prolonged trough — the distinction Carrying Value drew. The hard floor is the liquidity: $980.3 million of cash and restricted cash plus roughly $1.0 billion of fixed-term deposits, no bank borrowings, and a working-capital surplus of $2.19 billion at year-end 2025 [5]. That pool cannot be impaired by a lower polysilicon price. The soft floor is property, plant and equipment carried at $3.40 billion — 52.7% of the $6.45 billion balance sheet [6]. Its carrying value is price-contingent: the FY2025 impairment was nil only because prices rebounded, after a $175.6 million charge the year before.

Source: liquidity and PP&E from the FY2025 Annual Report, Consolidated Balance Sheets [7]; ADS equity value as reported.

Both floors sit above the ADS price, but neither is fully available to an ADS holder. The hard cash is largely trapped: only $311.2 million of it is U.S.-dollar cash at the Cayman parent, $3.23 billion of consolidated net assets are legally barred from distribution, and the upstreaming tap has collapsed with subsidiary losses [8] [9]. That is why a discount to book and to look-through cash can persist without being an arbitrage, as Where the Cash Sits and The Listing Gap established. The floors bound the downside; they do not by themselves close the gap.

The two floors are not independent. The polysilicon price is a single lever under both halves of Daqo's case: the late-2025 move above cost came only after Beijing's anti-involution push (prices surged >50% to RMB50-56/kg, then relapsed to ~RMB35-37/kg below cost by Q1 2026), and that same rebound is why Daqo recorded nil impairment on its $3,399.1 million of PP&E (57.5% of equity) in 2025 after a $175.6 million charge in 2024 — so one stalled policy decision both defers the recovery and re-arms the writedown on the book value that anchors the floor. The recoverability test behind that book number is set out in Carrying Value, where this finding carries the key-finding callout.

An above-cost price by mid-2026

What turns the balance-sheet option into a return is a polysilicon price above Daqo's cost, and in this cycle that is a policy outcome rather than a market one. In FY2025 the average selling price was $5.25/kg against a full production cost of $6.61/kg — a full year sold below cost [10] [11]. The first quarter of 2026 was worse: spot fell back below cost, Daqo took a $98.4 million inventory write-down, gross margin was negative 521%, and the net loss reached $88.4 million, or $1.31 per ADS [12]. Rather than sell into that, management withheld product — sales collapsed to 4,482 metric tons against 43,402 produced — to comply with the authorities' self-regulation guidelines [13].

Sources: ASP and cost from the FY2025 Annual Report [14] [15]; Q1 2026 ASP from the Q1 2026 call [16]; mooted floor per Waiting on Beijing.

The mechanism is now written into national policy. Anti-involution is a stated priority of China's 15th Five-Year Plan, the competition and pricing framework has been amended, and a proposed mandatory standard would cap energy consumption per unit of polysilicon — a rule that favors a low-energy producer [17]. On the Q1 call, management described a government consensus to enforce the price law, a fresh round of cost determination expected around midyear, and renewed minimum-price guidance to follow — but enforcement itself had not begun, leaving Daqo in what it called "observation mode" [18]. The mooted floor sits above Daqo's cost, as Waiting on Beijing detailed; if it is set there and enforced, Daqo returns to profit, and if it is not, the below-cost wait continues. The value range is most sensitive to which of those happens.

Three scenarios

The pillars combine into a spread that is asymmetric by construction: the downside is anchored to cash that cannot be impaired, while the upside is anchored to book and to the Shanghai mark. What separates them is enforcement and time.

Sources: cost floor [19]; utilization guidance [20]; enforcement path [21]; value anchors per Where the Cash Sits, The Listing Gap and Waiting on Beijing.

Two features of the downside are worth holding onto because they cut against the bear. First, even in a below-cost year the enterprise did not bleed: FY2025 operating cash flow was a positive $49.7 million, cushioned by $236.7 million of depreciation and non-cash write-downs, so the hard cash floor erodes slowly rather than abruptly [22]. Second, management has held utilization at 50-55% and can drop it further to cut the burn, as it has before [23]. The strongest fact against the upside is that the trigger is not in the company's hands — enforcement has been discussed, not delivered — and that the roughly 600,000 metric tons of industry inventory would cap any price rebound even if enforcement arrives [24].

There is a second condition on the upside that has nothing to do with polysilicon. A return to subsidiary profit only reaches the ADS if management chooses to send it there. Two $100 million ADS buyback programs sit unused at 0.19 times book while capital is reserved for consolidation and a new data-center venture [25]. As Capital Allocation argued, recovered cash could as easily fund tonnage or diversification as the discounted ADS. The upside case therefore needs two things to break the same way: policy, then priorities.

What to watch

Each of these is falsifiable, appears in a specific disclosure, and would move the read. They are the checkpoints between now and a resolved thesis.

Sources: enforcement and utilization from the Q1 2026 call [26] [27]; impairment, deferred-tax and buyback items per Carrying Value and Capital Allocation.

On the question that runs through the report — whether a low-cost, debt-free balance sheet can outlast the trough — the evidence points to a genuine floor and a genuine option, priced as though neither will pay off: at $12.25 the ADS is below its own look-through cash, and the assets behind it are marked near book by the same investors who own the Shanghai listing. What that option is worth turns on a policy decision expected by mid-2026 and on whether management then routes the proceeds to the discounted ADS. Until the mid-2026 cost re-determination lands and the first post-enforcement quarter is reported, the range stays wide — bounded below by cash, above by book, and unresolved in between.